Clinical trials
Completed Phase 3 Multiple Sclerosis, Chronic Progressive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| AB Science | 1 |
| Biogen | 1 |
| Genentech, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Sanofi | 1 |
| State University of New York at Buffalo | 1 |
| University College, London | 1 |
| University Hospital, Bordeaux | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 10 |
| Multiple Sclerosis | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.